News
1d
Mediaite on MSNWhite House Threatens Prescription Drug Makers With Price Controls: ‘We’ll Deploy Every Tool’ To Lower Prices
White House Press Secretary Karoline Leavitt announced at Thursday’s press conference that President Donald Trump had signed 17 letters to pharmaceutical company CEOs demanding they lower their prices ...
1d
Stocktwits on MSNTrump To Issue 60-Day Warning Letters To Drugmakers Over Pricing
White House Press Secretary Karoline Leavitt said on Thursday that President Donald Trump is set to send out letters to 17 ...
Trump sent a letter to 17 drug companies demanding a commitment to lower prices in the next 60 days through a series of initiatives.
Eli Lilly CEO David Ricks. (REUTERS/Leah Millis) (REUTERS / Reuters) He noted that many of the basic drugs used in hospitals, like antibiotics and the generics that Americans rely on, are made ...
When David Ricks became CEO of Eli Lilly, he faced the usual pressures of making the right, albeit risky, bets on the next big pharmaceutical breakthrough. But he also faced a unique challenge ...
Ricks on Friday said the company aims to bring its weight-loss pill to market in 2026. Eli Lilly shares rallied on the news, up 14% to $839.96. The stock is up around 8% year to date.
Jim Cramer Says Eli Lilly and Company (LLY) CEO David Ricks Is ‘Very Conservative’ Published on May 7, 2025 at 10:24 am by Ramish Cheema in News ...
So, David Ricks, Lilly’s CEO, was understandably cautious. It was the latest in a string of milestone moments for the understated leader of the country’s most dynamic pharmaceutical company.
But Eli Lilly CEO David Ricks waved off the deal Thursday, telling Yahoo Finance in an interview that the company is focused more on upcoming obesity drugs in its pipeline and sees exclusive deals ...
“We don’t believe tariffs are the right mechanism” to bolster U.S. drug manufacturing, Lilly Chief Executive David Ricks said on a conference call with analysts Thursday. The company ...
On an earnings call on Thursday, Eli Lilly CEO David Ricks said the company has been trying to move away from setting high list prices and paying bigger rebates to PBMs for preferential coverage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results